The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diab. Farxiga (dapagliflozin) is a diabetes medication that’s also fda approved to treat chronic kidney disease (ckd) These beneficial effects were consistent in patients with and without t2dm
simpqueen | mooooooo | Instagram
Acute kidney injury requiring hospitalization and dialysis has been reported in patients with type 2 diabetes mellitus receiving sglt2 inhibitors, including farxiga
Patients with impaired renal function (egfr less than 60 ml/min/1.73 m 2), elderly patients, or patients on loop diuretics may be at increased risk for volume depletion or hypotension.
Risks and side effects of farxiga using farxiga for chronic kidney disease (ckd) comes with potential risks and side effects that patients should be aware of Common side effects frequent urination urinary tract infections genital yeast. Farxiga was given once daily in addition to standard of care.
